Increase of activity of tioconazole against resistant microorganisms by the addition of butylated hydroxyanisole

International Journal of Antimicrobial Agents

Volumn 22, Issue 4, 2003, Pages 439-443

  Simonetti, Giovanna ^a   Simonetti, Nicola ^a   Villa, Adelaide ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Butylated hydroxyanisole; Microbicidal test; Resistant microorganisms; Tioconazole

Indexed keywords

ANTIOXIDANT; BUTYLATED HYDROXYANISOLE; TIOCONAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACTIVITY; DRUG POTENTIATION; ESCHERICHIA COLI; FUNGAL CELL; FUNGAL STRAIN; FUNGUS HYPHAE; HYDROPHOBICITY; MICROORGANISM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; VIRULENCE;

EID: 0141792535     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00120-1     Document Type: Article

References (29)

1. Clissold S.P., Heel R.C. Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses. Drugs. 31:1986;29-51.
2. Beggs W.H. Fungicidal activity of tioconazole in relation to growth phase of Candida albicans and Candida parapsilosis. Antimicrob. Agents Chemother. 26:1984;699-701.
3. Sud I.J., Feingold D.S. Heterogeneity of action mechanisms among antimycotic imidazoles. Antimicrob. Agents Chemother. 20:1981;71-74.
4. Odds F.C. Candida and candidosis: a review and bibliography. 2nd ed. 1988;Ballière Tindall, London.
5. Sud I.J., Feingold D.S. Mechanisms of action of the antimycotic imidazoles. J. Invest. Dermatol. 76:1981;438-441.
6. Iverson F. In vivo studies on butylated hydroxianisole. Food Chem. Toxicol. 37:1999;993-997.
7. Post L.S., Davidson P.M. Lethal effect of butylated hydroxyanisole as related to bacterial fatty acid composition. Appl. Environ. Microbiol. 52:(1):1986;214-216.
8. Shaidi F., Janitha P.K., Wanasundara P.D. Phenolic antioxidants. Crit. Rev. Food Sci. Nutr. 32:1992;67-103.
9. Ansehn S., Nilsson L. Direct membrane-damaging effect of ketoconazole and tioconazole on Candida albicans demonstrated by bioluminescent assay of ATP. Antimicrob. Agents Chemother. 26:1984;22-25.
10. Lefler E., Stevens D.A. Inhibition and killing of Candida albicans in vitro by five imidazoles in clinical use. Antimicrob. Agents Chemother. 25:1984;450-454.
11. Sgaragli G., Della Corte L., Rizzotti-Conti M., Giotti A. Effect of monocyclic compounds on biomembranes. Biochem. Pharmacol. 26:1997;2145-2149.
12. Johnson E.M., Richardon M.D., Warnock D.W. Effect of imidazole antifungals on the development of germ tubes by strains of Candida albicans. J. Antimicrob. Chemother. 12:1983;303-316.
13. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeast. Approved Standard M27-A. Wayne, PA: NCCLS; 1997.
14. National Committee for Clinical Laboratory Standards: Method for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved Standard M7-A2. Wayne, PA: NCCLS; 1991.
15. European Standard (EN 1275): Chemical disinfectants and antiseptics. Basic fungicidal activity. Test method and requirements (Phase 1), 1997.
16. Lindhal M., Faris A., Wadstrom T., Hjerten S. A new test based on 'salting out' to measure relative surface hydrophobicity of bacterial cells. Biochim. Biophys. Acta. 677:1981;471-476.
17. Simonetti N., Strippoli V., Cassone A. Yeast mycelial conversion induced by N-acetyl-D-glucosamine in C. albicans. Nature. 250:1974;344-346.
18. Simonetti N., D'Auria F.D., Strippoli V., Simonetti G. The inhibitory action of fluconazole on yeast-to-mycelial phase conversion in Candida albicans. Drug Invest. 4:1992;15-19.
19. Ha K.C., White T.C. Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans. Antimicrob. Agents Chemother. 43:1999;763-768.
20. Ghannoum M.A., Rice L.B. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 2:1999;501-517.
21. Shepherd M.G., Poulter R.T.M., Sullivan P.A. Candida albicans: biology, genetics and pathogenicity. Ann. Rev. Microbiol. 39:1985;579-614.
22. Antley P.P., Hazen K.C. Role of yeast cell growth temperature on Candida albicans virulence in mice. Infect. Immun. 56:1998;2884-2890.
23. Simonetti G., Baffa S., Simonetti N. Contact imidazole activity against resistant bacteria and fungi. Int. J. Antimicrob. Agents. 17:2001;389-393.
24. Andrews F.A., Beggs W.H., Sarosi G.A. Influence of antioxidants on the bioactivity of amphotericin B. Antimicrob. Agents Chemother. 11:1977;615-618.
25. Branen A.L. Toxicology and biochemistry of butylated hydroxyanisole and butylated hydroxytoluene. J. Am. Oil Chem. Soc. 52:1975;59-63.
26. Williams G.M., Iatropoulos M.J., Whysner J. Safety assessment of butylated hydroxyanisole and butylated hydroxytoluene as antioxidant food additives. Food Chem. Toxicol. 37:1999;1027-1038.
27. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56:1992;395-411.
28. Reeves D.S., Phillips I., Williams J.D., Wise R. In laboratory methods in antimicrobial chemotherapy. 1978;Churchill Livingstone, Edinburgh.
29. Shmeeda H.R., Golden E.B., Barenholz Y. Membrane lipids and aging. Shinitzky M. Biomembranes, structural and functional aspects. 1994;1-82 VCH Balabam, Weinheim.